Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Rocket Pharmaceuticals Inc. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Danon disease (DD) is a rare, X-linked disorder associated with severe cardiomyopathy, and in many cases, skeletal myopathy, and cognitive impairment caused by mutations in the LAMP2 gene. There is still uncertainty regarding the natural history of DD because of its rarity.
This study aims to determine the natural history of DD through the collection and analysis of retrospective and prospective data. To achieve this, the investigators will perform surveys and obtain medical records from DD patients. The same cohort of patients will also be assessed by a multidisciplinary team with expertise in DD (cardiologist, neurologist, ophthalmologist, psychologist, geneticist) at the University of California, San Diego. All patients with DD are eligible, including those who underwent a heart transplant. Additionally, data and records from deceased patients will provide valuable retrospective data for this study.
The study design will include:
Collection of information for all patients from:
Collection of information from living patients assessed by the multidisciplinary team at the University of California, San Diego including:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Danon Disease Patients | Patients with a confirmed diagnosis of Danon disease who are currently alive (including patients who may or may not have undergone heart transplantation). | ||
| Deceased Danon Disease Patients | Patients with a confirmed diagnosis of Danon disease who are deceased (including patients who may or may not have undergone heart transplantation). |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Cardiac structure over time | Change of cardiac structure (wall thickness -mm) measured by cardiac ultrasound / cardiac magnetic resonance | 6, 12, 18, 24, 30, 36 months |
Not provided
Not provided
Inclusion Criteria:
• Living or deceased patients with a diagnosis of Danon disease(including patients who may or may not have undergone heart transplantation) based on a genetic test positive for the LAMP2 mutation
Exclusion Criteria:
• Patients without a genetic test positive for a LAMP2 mutation
Not provided
Not provided
Patients diagnosed with Danon Disease (LAMP2 mutation) of any sex and any age.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Eric Adler, MD | Contact | 8582462996 | eradler@ucsd.edu |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California, San Diego | Recruiting | San Diego | California | 92122-5671 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40118805 | Derived | Hong KN, Eshraghian E, Khedro T, Argiro A, Attias J, Storm G, Tsotras M, Bloks T, Jackson I, Ahmad E, Graw S, Mestroni L, Bui QM, Schwartz J, Turner S, Adler ED, Taylor M. An International Longitudinal Natural History Study of Patients With Danon Disease: Unique Cardiac Trajectories Identified Based on Sex and Heart Failure Outcomes. J Am Heart Assoc. 2025 Apr;14(7):e038394. doi: 10.1161/JAHA.124.038394. Epub 2025 Mar 21. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D052120 | Glycogen Storage Disease Type IIb |
| ID | Term |
|---|---|
| D038901 | X-Linked Intellectual Disability |
| D008607 | Intellectual Disability |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
Not provided
Not provided
Not provided
Not provided
Not provided
| D009422 | Nervous System Diseases |
| D009202 | Cardiomyopathies |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D040181 | Genetic Diseases, X-Linked |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D006008 | Glycogen Storage Disease |
| D002239 | Carbohydrate Metabolism, Inborn Errors |
| D008661 | Metabolism, Inborn Errors |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |